Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day

Author's Avatar
Feb 05, 2021
Article's Main Image

Five+Prime+Therapeutics%2C+Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer, are scheduled to participate in a fireside chat at the virtual Guggenheim Healthcare Talks: Oncology Day on Friday, February 12, 2021 at 1:00 p.m. ET/10:00 a.m. PT.